Peer Review Process
Mathews Open Access Journals follows double blind peer review process. In this we do not reveal author names, affiliations to the reviewer and vice versa. We adhere to the Committee on Publication Ethics (COPE), code of conduct, and best practice guidelines (http://publicationethics.org). We strive to ensure that the peer review is fair, unbiased and timely. Decisions to accept or reject a manuscript for publication in the journal are based on the manuscript’s importance, originality, clarity, and the study’s validity and its relevance to remit of the journal. The process also involves strictly no plagiarism or fabrication of the data and parallel submissions.
Responsibilities
Being a reviewer you are accountable to take the responsibility of maintaining confidentiality of ideas that have been presented in the papers assigned to review. Focus your evaluation on merits and demerits of the article; assess the correctness, accuracy, clarity, and innovation of the research. Never reveal the assigned paper's results or videos/images or any of the supplementary material to non-reviewers.
The reviewers are given ample time for the review and submission of comments to the editorial office. Reviewers’ evaluations play a major role in our decision as to whether to accept a manuscript for publication.
Ethical Issues
Published : 05th July 2024
Authors : Ezegbe Chekwube Andrew1,4,* Anikwe Celestine Chidera2, Uzondu Samuel WisdomofGod3,4, Okorie James Ekemezie1, Okafor Nnedimma Pauline1, Ezegbe Amarachi Grace5, Agu Kenechukwu Christian1, Okorafor Ezinne Chinemerem6, Aniagwu Ifunanya Sheila1
Citation : Andrew EC, et al. (2024). Formulation and in Vitro Evaluation of Liquisolid Compact of Celecoxib. Mathews J Pharma Sci. 8(2):31.
Published : 02nd July 2024
Authors : Vaibhav Adhao*, Jaya Ambhore, Anant Bhuskat, Dishali Talokar
Citation : Adhao V, et al. (2024). A Review on Analytical Methodologies for the Estimation of Anti-Retroviral Drugs Cabotegravir and Rilpivirine. Mathews J Pharma Sci. 8(1):30.
Published : 28th June 2024
Authors : Paolo Zanirato1,*, Silvia Businelli2
Citation : Zanirato P, et al. (2024). Synthesis and Antidiseas Evaluation of Some Bis-Heteroaryls (Thiophene or Selenophene) 1,2,3-triazoles C-trimethylsilylated. Mathews J Pharma Sci. 8(1):29.
Published : 13th June 2024
Authors : Amarachi Salome Chime1, Chekwube Andrew Ezegbe1,3,* Chidinma Judith Iyanyi1, Chukwunwike Godswill Onunkwo1, Amarachi Grace Ezegbe2, Nnedimma Pauline Okafor1
Citation : Chime AS, et al. (2024). Formulation, In-Vitro and In-Vivo Evaluation of Lamivudine-Loaded Solid Lipid Nanoparticles (SLNs). Mathews J Pharma Sci. 8(1):28.
Published : 18th May 2024
Authors : Ferruccio Trifirò*, Paolo Zanirato#
Citation : Trifirò F, et al. (2024). The Battle of the Physic and Chemistry against Pathogenic Microorganism. Mathews J Pharma Sci. 8(1):27.
Published : 01st April 2024
Author : Marjan Dzeparoski1,2,*
Citation : Dzeparoski M. (2024). Regulatory Update on eSubmissions in Balkans. Mathews J Pharma Sci. 8(1):26.